Corient Capital Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | $12.8M | Hold |
140,938
| – | – | 0.96% | 15 |
|
2022
Q2 | $12.8M | Buy |
140,938
+5,247
| +4% | +$478K | 0.97% | 16 |
|
2022
Q1 | $11.1M | Buy |
135,691
+6,186
| +5% | +$508K | 0.74% | 23 |
|
2021
Q4 | $9.93M | Buy |
129,505
+4,550
| +4% | +$349K | 0.66% | 29 |
|
2021
Q3 | $9.39M | Buy |
124,955
+11,767
| +10% | +$884K | 0.69% | 27 |
|
2021
Q2 | $8.8M | Buy |
113,188
+15,312
| +16% | +$1.19M | 0.64% | 29 |
|
2021
Q1 | $7.2M | Buy |
97,876
+2,445
| +3% | +$180K | 0.62% | 34 |
|
2020
Q4 | $7.45M | Buy |
95,431
+2,250
| +2% | +$176K | 0.74% | 28 |
|
2020
Q3 | $7.38M | Buy |
93,181
+5,233
| +6% | +$414K | 0.85% | 20 |
|
2020
Q2 | $6.49M | Buy |
87,948
+13,203
| +18% | +$974K | 0.79% | 27 |
|
2020
Q1 | $5.49M | Buy |
74,745
+18,275
| +32% | +$1.34M | 0.87% | 25 |
|
2019
Q4 | $4.9M | Buy |
56,470
+681
| +1% | +$59.1K | 0.62% | 33 |
|
2019
Q3 | $4.48M | Buy |
55,789
+10,350
| +23% | +$831K | 0.63% | 35 |
|
2019
Q2 | $3.64M | Buy |
45,439
+2,315
| +5% | +$185K | 0.56% | 39 |
|
2019
Q1 | $3.42M | Buy |
43,124
+14,022
| +48% | +$1.11M | 0.56% | 36 |
|
2018
Q4 | $2.12M | Buy |
29,102
+5,955
| +26% | +$434K | 0.38% | 67 |
|
2018
Q3 | $1.57M | Hold |
23,147
| – | – | 0.26% | 114 |
|
2018
Q2 | $1.34M | Buy |
23,147
+3,383
| +17% | +$196K | 0.23% | 125 |
|
2018
Q1 | $1.03M | Sell |
19,764
-3,592
| -15% | -$187K | 0.19% | 124 |
|
2017
Q4 | $1.25M | Sell |
23,356
-1,519
| -6% | -$81.6K | 0.21% | 115 |
|
2017
Q3 | $1.52M | Sell |
24,875
-2,867
| -10% | -$175K | 0.29% | 90 |
|
2017
Q2 | $1.7M | Buy |
27,742
+369
| +1% | +$22.6K | 0.26% | 102 |
|
2017
Q1 | $1.66M | Buy |
27,373
+218
| +0.8% | +$13.2K | 0.26% | 100 |
|
2016
Q4 | $1.53M | Sell |
27,155
-544
| -2% | -$30.6K | 0.27% | 100 |
|
2016
Q3 | $1.65M | Buy |
+27,699
| New | +$1.65M | 0.31% | 91 |
|